Immunochemotherapy with rituximab and te
β
Eric T. Wong; Roy Tishler; Loretta Barron; Julian K. Wu
π
Article
π
2004
π
John Wiley and Sons
π
English
β 172 KB
## Abstract ## BACKGROUND Methotrexateβbased and alkylatorβbased chemotherapy regimens are associated with renal and bone marrow toxicities, which limit their use in patients with central nervous system (CNS) lymphomas. The authors report their experience with an immunochemotherapy regimen consist